NHS rolls out “more convenient” Ocrevus injection for multiple sclerosis
The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.
Neurology
Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
TauRx seeks UK MHRA approval for Alzheimer’s treatment
Eisai and Biogen launch LEQEMBI for Alzheimer’s in China
FDA issues complete response to AbbVie’s NDA for Parkinson’s drug
Ascidian and Roche to develop RNA therapies for neurological diseases
Alzheon secures $100m to advance Alzheimer’s disease treatment
Monthly IV version of Leqembi set for FDA review by next year
